17-Apr-2024 16:31 |
37.00p |
3,300 |
£1,221 |
Sell |
O |
17-Apr-2024 16:01 |
37.06p |
7,500 |
£2,780 |
Sell |
O |
17-Apr-2024 16:00 |
37.06p |
1,283 |
£476 |
Sell |
O |
17-Apr-2024 14:28 |
37.62p |
786 |
£296 |
Buy |
O |
17-Apr-2024 14:19 |
37.80p |
3,000 |
£1,134 |
Buy |
O |
17-Apr-2024 12:06 |
38.00p |
500 |
£190 |
Buy |
O |
17-Apr-2024 11:00 |
38.00p |
7 |
£3 |
Buy |
O |
17-Apr-2024 10:07 |
37.09p |
3,000 |
£1,113 |
Sell |
O |
17-Apr-2024 10:05 |
37.00p |
150 |
£56 |
Sell |
O |
17-Apr-2024 10:02 |
37.00p |
3 |
£1 |
Sell |
O |
17-Apr-2024 08:47 |
37.16p |
2,535 |
£942 |
Sell |
O |
16:31 |
3,300 @ 37.00p |
16:01 |
7,500 @ 37.06p |
16:00 |
1,283 @ 37.06p |
14:28 |
786 @ 37.62p |
14:19 |
3,000 @ 37.80p |
CFO |
Judy Amanda Happe |
CEO |
James Hickman |
Top of Page
You are here:
research